194 related articles for article (PubMed ID: 34650051)
1. The tyrosine-kinase inhibitor Nintedanib ameliorates autosomal-dominant polycystic kidney disease.
Jamadar A; Suma SM; Mathew S; Fields TA; Wallace DP; Calvet JP; Rao R
Cell Death Dis; 2021 Oct; 12(10):947. PubMed ID: 34650051
[TBL] [Abstract][Full Text] [Related]
2. Myofibroblast depletion reduces kidney cyst growth and fibrosis in autosomal dominant polycystic kidney disease.
Dwivedi N; Jamadar A; Mathew S; Fields TA; Rao R
Kidney Int; 2023 Jan; 103(1):144-155. PubMed ID: 36273656
[TBL] [Abstract][Full Text] [Related]
3. Metformin improves relevant disease parameters in an autosomal dominant polycystic kidney disease mouse model.
Pastor-Soler NM; Li H; Pham J; Rivera D; Ho PY; Mancino V; Saitta B; Hallows KR
Am J Physiol Renal Physiol; 2022 Jan; 322(1):F27-F41. PubMed ID: 34806449
[TBL] [Abstract][Full Text] [Related]
4. A study of sirolimus and mTOR kinase inhibitor in a hypomorphic
Holditch SJ; Brown CN; Atwood DJ; Lombardi AM; Nguyen KN; Toll HW; Hopp K; Edelstein CL
Am J Physiol Renal Physiol; 2019 Jul; 317(1):F187-F196. PubMed ID: 31042058
[TBL] [Abstract][Full Text] [Related]
5. The lonidamine derivative H2-gamendazole reduces cyst formation in polycystic kidney disease.
Sundar SV; Zhou JX; Magenheimer BS; Reif GA; Wallace DP; Georg GI; Jakkaraj SR; Tash JS; Yu ASL; Li X; Calvet JP
Am J Physiol Renal Physiol; 2022 Oct; 323(4):F492-F506. PubMed ID: 35979967
[TBL] [Abstract][Full Text] [Related]
6. VEGF receptor inhibition blocks liver cyst growth in pkd2(WS25/-) mice.
Amura CR; Brodsky KS; Groff R; Gattone VH; Voelkel NF; Doctor RB
Am J Physiol Cell Physiol; 2007 Jul; 293(1):C419-28. PubMed ID: 17475663
[TBL] [Abstract][Full Text] [Related]
7. STAT5 drives abnormal proliferation in autosomal dominant polycystic kidney disease.
Fragiadaki M; Lannoy M; Themanns M; Maurer B; Leonhard WN; Peters DJ; Moriggl R; Ong AC
Kidney Int; 2017 Mar; 91(3):575-586. PubMed ID: 28104302
[TBL] [Abstract][Full Text] [Related]
8. Ouabain enhances renal cyst growth in a slowly progressive mouse model of autosomal dominant polycystic kidney disease.
Trant J; Sanchez G; McDermott JP; Blanco G
Am J Physiol Renal Physiol; 2023 Dec; 325(6):F857-F869. PubMed ID: 37823195
[TBL] [Abstract][Full Text] [Related]
9. Sirtuin 1 inhibition delays cyst formation in autosomal-dominant polycystic kidney disease.
Zhou X; Fan LX; Sweeney WE; Denu JM; Avner ED; Li X
J Clin Invest; 2013 Jul; 123(7):3084-98. PubMed ID: 23778143
[TBL] [Abstract][Full Text] [Related]
10. Double inhibition of cAMP and mTOR signalling may potentiate the reduction of cell growth in ADPKD cells.
de Stephanis L; Bonon A; Varani K; Lanza G; Gafà R; Pinton P; Pema M; Somlo S; Boletta A; Aguiari G
Clin Exp Nephrol; 2017 Apr; 21(2):203-211. PubMed ID: 27278932
[TBL] [Abstract][Full Text] [Related]
11. Ablation of Long Noncoding RNA Hoxb3os Exacerbates Cystogenesis in Mouse Polycystic Kidney Disease.
Weisser I; Eckberg K; D'Amico S; Buttram D; Aboudehen K
J Am Soc Nephrol; 2024 Jan; 35(1):41-55. PubMed ID: 37953472
[TBL] [Abstract][Full Text] [Related]
12. Steviol retards renal cyst growth through reduction of CFTR expression and inhibition of epithelial cell proliferation in a mouse model of polycystic kidney disease.
Yuajit C; Muanprasat C; Gallagher AR; Fedeles SV; Kittayaruksakul S; Homvisasevongsa S; Somlo S; Chatsudthipong V
Biochem Pharmacol; 2014 Apr; 88(3):412-21. PubMed ID: 24518257
[TBL] [Abstract][Full Text] [Related]
13. Integrin-Linked Kinase Signaling Promotes Cyst Growth and Fibrosis in Polycystic Kidney Disease.
Raman A; Reif GA; Dai Y; Khanna A; Li X; Astleford L; Parnell SC; Calvet JP; Wallace DP
J Am Soc Nephrol; 2017 Sep; 28(9):2708-2719. PubMed ID: 28522687
[TBL] [Abstract][Full Text] [Related]
14. Epithelial Vasopressin Type-2 Receptors Regulate Myofibroblasts by a YAP-CCN2-Dependent Mechanism in Polycystic Kidney Disease.
Dwivedi N; Tao S; Jamadar A; Sinha S; Howard C; Wallace DP; Fields TA; Leask A; Calvet JP; Rao R
J Am Soc Nephrol; 2020 Aug; 31(8):1697-1710. PubMed ID: 32554753
[TBL] [Abstract][Full Text] [Related]
15. Expression of active B-Raf proto-oncogene in kidney collecting ducts induces cyst formation in normal mice and accelerates cyst growth in mice with polycystic kidney disease.
Parnell SC; Raman A; Zhang Y; Daniel EA; Dai Y; Khanna A; Reif GA; Vivian JL; Fields TA; Wallace DP
Kidney Int; 2022 Nov; 102(5):1103-1114. PubMed ID: 35760151
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of TGF-β1 induces renal fibrosis and accelerates the decline in kidney function in polycystic kidney disease.
Zhang Y; Dai Y; Raman A; Daniel E; Metcalf J; Reif G; Pierucci-Alves F; Wallace DP
Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1135-F1148. PubMed ID: 33166182
[TBL] [Abstract][Full Text] [Related]
17. The effect of trehalose on autophagy-related proteins and cyst growth in a hypomorphic Pkd1 mouse model of autosomal dominant polycystic kidney disease.
Atwood DJ; Brown CN; Holditch SJ; Pokhrel D; Thorburn A; Hopp K; Edelstein CL
Cell Signal; 2020 Nov; 75():109760. PubMed ID: 32866627
[TBL] [Abstract][Full Text] [Related]
18. Lysine methyltransferase SMYD2 promotes cyst growth in autosomal dominant polycystic kidney disease.
Li LX; Fan LX; Zhou JX; Grantham JJ; Calvet JP; Sage J; Li X
J Clin Invest; 2017 Jun; 127(7):2751-2764. PubMed ID: 28604386
[TBL] [Abstract][Full Text] [Related]
19. Extracellular vesicles and exosomes generated from cystic renal epithelial cells promote cyst growth in autosomal dominant polycystic kidney disease.
Ding H; Li LX; Harris PC; Yang J; Li X
Nat Commun; 2021 Jul; 12(1):4548. PubMed ID: 34315885
[TBL] [Abstract][Full Text] [Related]
20. c-Src inactivation reduces renal epithelial cell-matrix adhesion, proliferation, and cyst formation.
Elliott J; Zheleznova NN; Wilson PD
Am J Physiol Cell Physiol; 2011 Aug; 301(2):C522-9. PubMed ID: 21508333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
